Reed Elsevier PLC
08 January 2008
ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
8 January 2008
Director/PDMR Shareholding
Following the share consolidation, which took place on 7 January 2008, whereby
Reed Elsevier PLC shareholders received 58 new ordinary shares of 14 51/116
pence for every 67 ordinary shares of 12.5p and Reed Elsevier NV shareholders
received 58 new ordinary shares of €0.07 for every 67 ordinary shares of €0.06
held, the directors interests in the issued share capital of Reed Elsevier is
now as follows:
Director New ordinary shares in New ordinary shares in
Reed Elsevier PLC Reed Elsevier NV
G van de Aast 107,591 104,333
M Armour 97,282 41,085
C Davis 681,783 385,394
E Engstrom 68,716 190,332
A Prozes 199,953 146,587
P Tierney 32,389 22,029
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.